The cover picture shows a potent epothilone derivative with a schematized tubulin microtubule in the background. Epothilones exert their antitumor activity through the stabilization of microtubules by binding with tubulin; cell division stops if microtubules cannot disassemble properly. The structure shown here is the most potent epothilone reported to date. It is more potent than epothilone B in a wide range of cancer cell types, and shows excellent promise against taxol‐ and epothilone A‐resistant cell lines. For more details, see the communication by K. C. Nicolaou et al. on p. 41 ff.